Target ALS is pleased to share a copy of our 2021 annual report, which outlines our many expansive and successful activities that advanced ALS research last year. See below for a letter from our founder Dan Doctoroff, followed by a copy of the report.
Dear Friends and Colleagues,
We all hoped we would finally return to normal in 2021. But despite the ongoing challenges caused by the COVID-19 pandemic, I am amazed at what Target ALS has continued to accomplish. We have forged ahead with our funding for breakthrough research; established a one-of-a-kind scientific core; nurtured important new alliances, including across related neurodegenerative diseases; and helped bring more attention to the fight against ALS.
All these encouraging signs came in a year in which I was given a likely ALS diagnosis. As a result, I’ve pulled back from many of my responsibilities so that I can focus on two life-affirming activities: spending more time with friends and family and helping advance ALS research.
We are all working together to create a world in which everyone with an ALS diagnosis lives a long, high-quality life. Thank you for bringing us to a place where the achievement of these goals may be possible.
Yours in this fight against ALS,
Daniel L. Doctoroff
Founder
